← Back to all substances
C

amlodipine

197ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

1 INDICATIONS AND USAGE Amlodipine besylate tablets are calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: •Hypertension ( 1.1 ) о Amlodipine besylate tablets are indicated for the treatment of hypertension, to low...

Known as: Amlodipine Besylate
Route: ORAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
351,433
Total in FDA
77%
Serious Reports
57
Fatal Outcomes

Seriousness

Serious
384
Non-Serious
116

Sex Distribution

Male
194
Female
285
Unknown
21

Age Distribution

0-17
2
18-40
19
41-64
165
65-84
211
85+
31
Unknown
72

Outcomes

Recovered/Resolved
385
Recovering/Resolving
113
Not Recovered/Not Resolved
382
Recovered with Sequelae
15
Fatal
57
Unknown
769

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-96fa0c
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...